Kainos Medicine Inc (284620) — Financial Flexibility Index

Latest as of March 2025: -0.37x

Kainos Medicine Inc (284620) has a Financial Flexibility Index of -0.37x as of March 2025. Free cash flow of ₩-2.93 Billion (operating CF ₩-2.97 Billion minus capex ₩40.29 Million) represents 0% of total liabilities (₩7.97 Billion). Also explore 284620 net assets growth trend to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.37x
Free Cash Flow / Total Liabilities

Free Cash Flow

₩-2.93 Billion
Operating CF − Capex

Total Liabilities

₩7.97 Billion
KRW

Capital Expenditures

₩40.29 Million
KRW

Kainos Medicine Inc Financial Flexibility Index (2017–2024)

Historical Financial Flexibility Index trend for Kainos Medicine Inc across 8 annual periods. Check Kainos Medicine Inc (284620) strategic investment index to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Kainos Medicine Inc (2017–2024)

Year-by-year free cash flow to debt coverage for Kainos Medicine Inc. For the full company profile including market capitalisation, see 284620 market cap.

Year Flexibility Index Free Cash Flow (KRW) Operating CF Total Liabilities YoY Change
2024 -1.06x ₩-9.50 Billion ₩-9.71 Billion ₩8.95 Billion ▲ +3.2%
2023 -1.10x ₩-10.12 Billion ₩-14.22 Billion ₩9.23 Billion ▼ -59.8%
2022 -0.69x ₩-8.83 Billion ₩-11.30 Billion ₩12.87 Billion ▼ -201.2%
2021 -0.23x ₩-6.80 Billion ₩-9.20 Billion ₩29.85 Billion ▲ +20.0%
2020 -0.28x ₩-6.39 Billion ₩-7.61 Billion ₩22.43 Billion ▼ -221.1%
2019 0.24x ₩185.74 Million ₩185.74 Million ₩789.89 Million ▲ +924.8%
2018 -0.03x ₩-22.01 Million ₩-22.01 Million ₩772.06 Million ▲ +22.5%
2017 -0.04x ₩-27.23 Million ₩-27.23 Million ₩740.19 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities